As of September 2026, 546 paid clinical trials are recruiting in Duarte, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Duarte offers studies at sites including City of Hope Medical Center for conditions such as Acute Myeloid Leukemia, Ovarian Cancer, Breast Cancer, Colorectal Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Duarte, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Myelodysplastic Syndrome | 180 |
| City of Hope | Breast Cancer, Gastric Cancer, Cervical Cancer | 136 |
| City of Hope Comprehensive Cancer Center | Metastatic Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm | 81 |
| City of Hope National Medical Center | Solid Tumor, Advanced Solid Tumor, Advanced/Metastatic Solid Tumors | 52 |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Pancreatic Ductal Adenocarcinoma, Advanced Breast Cancer, Advanced Renal Cell Carcinoma | 9 |
| City of Hope - Duarte Cancer Center | Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma | 6 |
| City of Hope Cancer Center | Advanced Solid Tumors, Cervical Cancer, Colorectal Cancer | 6 |
| City of Hope - Duarte | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Anemia, KRAS G12C-mutated Solid Tumors, Lung Cancer | 5 |
| City of Hope Duarte | Multiple Myeloma, Advanced Colorectal Cancer, CRC | 3 |
| City of Hope Cancer Center (Data collection only) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Ascentage Investigative | CML, CML, Chronic Phase, Chronic Myeloid Leukemia | 2 |
| Beckman Research Institute of City of Hope | Cancer, End of Life, Prostate Cancer | 2 |
| City of Hope Investigational Drug Services (IDS) | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 2 |
| City of Hope National Cancer Center | Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction | 2 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 2 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Myelodysplastic Syndromes | 2 |
| Beckman Research Institute of the City of Hope | Prostate Adenocarcinoma | 1 |
| City Of Hope Comprehensive Cancer Center | Advanced Squamous Tumors | 1 |
| City of Hope - Comprehensive Cancer Center (CCC) | Anemia, Myelodysplastic Syndrome | 1 |
| City of Hope - Duarte Main Site | Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis | 1 |
| City of Hope - National Medical Center | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| City of Hope -Duarte Cancer Center | Ductal Carcinoma in Situ | 1 |
| City of Hope Blood Donor Center | Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia | 1 |
| City of Hope Cancer Center (Data collection AND Specimen Analysis) | Acute Lymphoblastic Leukemia | 1 |
| City of Hope Center | Myelofibrosis, Secondary AML | 1 |
Recruiting trials in Duarte grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 546 recruiting clinical trials in Duarte, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Duarte compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Duarte include Acute Myeloid Leukemia (22), Ovarian Cancer (14), Breast Cancer (13), Colorectal Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Duarte on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Duarte include City of Hope Medical Center, City of Hope, City of Hope Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Duarte are Cancer & tumors (405), Diabetes & metabolic (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.